AU2002242447A1 - Use of polyclonal immunoglobulins - Google Patents
Use of polyclonal immunoglobulinsInfo
- Publication number
- AU2002242447A1 AU2002242447A1 AU2002242447A AU2002242447A AU2002242447A1 AU 2002242447 A1 AU2002242447 A1 AU 2002242447A1 AU 2002242447 A AU2002242447 A AU 2002242447A AU 2002242447 A AU2002242447 A AU 2002242447A AU 2002242447 A1 AU2002242447 A1 AU 2002242447A1
- Authority
- AU
- Australia
- Prior art keywords
- polyclonal immunoglobulins
- immunoglobulins
- polyclonal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229940072221 IMMUNOGLOBULINS Drugs 0.000 title 1
- 102000018358 Immunoglobulins Human genes 0.000 title 1
- 108060003951 Immunoglobulins Proteins 0.000 title 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT0086001A AT410637B (en) | 2001-06-01 | 2001-06-01 | USE OF POLYCLONAL IMMUNOGLOBULINES |
| ATA860/2001 | 2001-06-01 | ||
| PCT/AT2002/000088 WO2002096455A2 (en) | 2001-06-01 | 2002-03-19 | Use of polyclonal immunoglobulins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002242447A1 true AU2002242447A1 (en) | 2003-05-08 |
| AU2002242447B2 AU2002242447B2 (en) | 2007-11-08 |
Family
ID=3682339
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002242447A Ceased AU2002242447B2 (en) | 2001-06-01 | 2002-03-19 | Use of polyclonal immunoglobulins |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20040151717A1 (en) |
| EP (1) | EP1399185A2 (en) |
| JP (1) | JP2004532261A (en) |
| CN (1) | CN1512895A (en) |
| AT (1) | AT410637B (en) |
| AU (1) | AU2002242447B2 (en) |
| BR (1) | BR0210239A (en) |
| CA (1) | CA2449026A1 (en) |
| CZ (1) | CZ20033273A3 (en) |
| HU (1) | HUP0400031A3 (en) |
| IL (2) | IL158950A0 (en) |
| MX (1) | MXPA03010829A (en) |
| NO (1) | NO20035282D0 (en) |
| PL (1) | PL367835A1 (en) |
| SK (1) | SK14662003A3 (en) |
| WO (1) | WO2002096455A2 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10127712A1 (en) * | 2001-06-07 | 2002-12-19 | Torsten Witte | Use of immunoglobulin M for treatment and prevention of systemic lupus erythematosus, administered subcutaneously or intramuscularly |
| WO2005023867A1 (en) * | 2003-09-08 | 2005-03-17 | Medical Research Council | Method for the treatment or prophylaxis of tuberculosis |
| BR112017010442A2 (en) * | 2014-12-03 | 2017-12-26 | Csl Behring Ag | pharmaceutical product, uses a polymer syringe, oxygen sequestering compound, and immunoglobulin solution |
| FR3072880A1 (en) * | 2017-10-30 | 2019-05-03 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | LIPOSOMAL FORMULATION AND USE THEREOF IN ANTI-TUMOR THERAPY |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3340487A1 (en) * | 1983-11-09 | 1985-05-15 | Sandoz-Patent-GmbH, 7850 Lörrach | Novel therapeutic use |
| SG46445A1 (en) * | 1990-01-26 | 1998-02-20 | Immunomedics Inc | Vaccines against cancer and infectious diseases |
| JP2795289B2 (en) * | 1990-09-04 | 1998-09-10 | 富士通株式会社 | Printed board unit holding structure in electronic equipment |
| US5219578A (en) * | 1991-02-25 | 1993-06-15 | Innovet, Inc. | Composition and method for immunostimulation in mammals |
| WO1992015885A1 (en) * | 1991-03-11 | 1992-09-17 | Idec Pharmaceuticals Corporation | Methods for selecting antibody reagents; anti-idiotype antibodies; and aids vaccine formulations |
| US5562902A (en) * | 1994-03-14 | 1996-10-08 | Arp Biomed, Inc. | Immunotherapeutic method of treating cancerous diseases by administration of intravenous immunoglobulin |
| US6462187B1 (en) * | 2000-06-15 | 2002-10-08 | Millennium Pharmaceuticals, Inc. | 22109, a novel human thioredoxin family member and uses thereof |
| TWI248819B (en) * | 1999-09-27 | 2006-02-11 | Arp Biomed Ltd | Pharmaceutical composition containing IVIG for use in treating lymphoma |
| AT409086B (en) * | 1999-11-16 | 2002-05-27 | Igeneon Krebs Immuntherapie | NEW USE OF ANTIBODIES AS VACCINE |
| AT410636B (en) * | 2001-03-23 | 2003-06-25 | Igeneon Krebs Immuntherapie | METHOD FOR PRODUCING A VACCINE |
-
2001
- 2001-06-01 AT AT0086001A patent/AT410637B/en not_active IP Right Cessation
-
2002
- 2002-03-19 CA CA002449026A patent/CA2449026A1/en not_active Abandoned
- 2002-03-19 CN CNA028111214A patent/CN1512895A/en active Pending
- 2002-03-19 AU AU2002242447A patent/AU2002242447B2/en not_active Ceased
- 2002-03-19 HU HU0400031A patent/HUP0400031A3/en unknown
- 2002-03-19 EP EP02707990A patent/EP1399185A2/en not_active Withdrawn
- 2002-03-19 CZ CZ20033273A patent/CZ20033273A3/en unknown
- 2002-03-19 MX MXPA03010829A patent/MXPA03010829A/en unknown
- 2002-03-19 SK SK1466-2003A patent/SK14662003A3/en not_active Application Discontinuation
- 2002-03-19 BR BR0210239-0A patent/BR0210239A/en not_active Application Discontinuation
- 2002-03-19 IL IL15895002A patent/IL158950A0/en active IP Right Grant
- 2002-03-19 PL PL02367835A patent/PL367835A1/en not_active Application Discontinuation
- 2002-03-19 US US10/478,942 patent/US20040151717A1/en not_active Abandoned
- 2002-03-19 WO PCT/AT2002/000088 patent/WO2002096455A2/en active Application Filing
- 2002-03-19 JP JP2002592964A patent/JP2004532261A/en active Pending
-
2003
- 2003-11-19 IL IL158950A patent/IL158950A/en not_active IP Right Cessation
- 2003-11-27 NO NO20035282A patent/NO20035282D0/en not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002256895A1 (en) | Anti-TRAIL-R antibodies | |
| IL149701A0 (en) | Use of anti-ctla-4 antibodies | |
| AU2002251562A1 (en) | Anti-CD40 monoclonal antibody | |
| EP1442061A4 (en) | Reducing immunogenicities of immunoglobulins by framework-patching | |
| EP1432444A4 (en) | Anti-a-beta antibodies | |
| EP1396500A4 (en) | Anti-trail-r antibodies | |
| AU2002360375A1 (en) | Synthesis strategies based on the appropriate use of inductance effects | |
| AU2002365649A8 (en) | Anti-dota antibody | |
| AU2002352221A1 (en) | Bicyclic n-arylamides | |
| AU2002342310A1 (en) | Modification of drawn film | |
| AU2002336311A1 (en) | Bicyclic compound | |
| HUP0500734A3 (en) | Use of 2-alkoxyphenyl-substituted imidazotriazinones | |
| AU2002216847A1 (en) | Epitopes of pai-1 | |
| AU2002242447A1 (en) | Use of polyclonal immunoglobulins | |
| AU2002358638A1 (en) | Catadioptric reduction lens | |
| IL158950A0 (en) | Use of polyclonal immunoglobulins | |
| EP1393746A4 (en) | Human polyclonal antibody compositions | |
| AU2002367161A1 (en) | Immunoglobulin composition | |
| AU2002350154A1 (en) | Preparation of polyethylene | |
| AU2002248038A1 (en) | Human polyclonal antibody compositions | |
| AU2002359898A1 (en) | Preparation of alpha-diimines | |
| HU0104370D0 (en) | Honeyed schnaps of oerseg | |
| AU2002211364A1 (en) | Human anti-cd40 antibodies | |
| AUPR399701A0 (en) | Determination of snoring | |
| TW545542U (en) | Structure of change over valve |